Zach Reitano

Patients Rarely Control the Money That Shapes Their Healthcare

Ro co-founder and CEO Zach Reitano argues that a central flaw in US healthcare is that patients receive care without controlling most of the money spent on it. In his account, direct payment makes patients the customer and can push prices down while improving care; he cites cash-pay GLP-1 prices falling from $1,300 to $149 as an example. Reitano says healthcare spending should be judged by its results, and that patients should have more say in choosing and paying for care.